Fig. 3
From: A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
Time to onset of brodumab-induced adverse events.
Fig. 3 | Scientific Reports
From: A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system
Time to onset of brodumab-induced adverse events.
